Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

US pre-open: Futures edge higher, but gains limited ahead of payrolls data

(Sharecast News) - Wall Street indices were trading with small gains in pre-market dealings with investors mostly choosing to keep their powder dry ahead of the all-important non-farm payrolls data due out at 0830 ET.

By 0622 ET, futures on the Dow, S&P 500 and Nasdaq were all up 0.2%, after closing with losses of around 0.1% on Thursday.

The ADP Employment Report on Wednesday showed that just 89,000 jobs were created in September, down from an upwardly revised 180,000 the previous month and well below the 160,000 expected by analysts.

However, the 'official' non-farm payrolls report, can often contrast with the ADP figures and is expected to show that job creation eased to 170,000 last month, from 187,000 previously.

"The report was likely to be pivotal in determining whether the Fed would hike rates at its next policy meeting in November," said Manoj Ladwa at ARJ Capital.

"However, uncertainties regarding the longer-term rate outlook were expected to persist. The labor market report is expected to show continued strength, with forecasts of moderate job growth, a decline in the unemployment rate, and modest wage growth. These factors would provide some justification for another rate hike by the Fed but may not offer a clear-cut decision, especially considering recent increases in bond yields, which could be perceived as tightening financial conditions."

The yield on a 10-year US Treasury note was up 3.5 basis points at 4.743% ahead of the opening bell in New York, after hitting a high of 4.887% earlier in the week - a fresh 16-year peak.

In company news, Exxon Mobil was making headlines on reports it is close to sealing a $60bn takeover of Pioneer Natural Resources. Exxon's shares were 2% lower in pre-market trade while Pioneer futures surged 11%.

G1 Therapeutics and Apellis Pharmaceuticals were both reacting to ratings changes by JP Morgan. G1 was hit with a downgrade to 'underweight', while Apellis was lifted by an upgrade to 'neutral'.

Share this article

Related Sharecast Articles

Europe close: Carmakers drive markets lower as earnings disappoint
(Sharecast News) - European stock markets finished with heavy losses on Tuesday, with the exception of the UK's FTSE 100, with positive eurozone GDP data failing to lift the mood following some disappointing corporate results from some the region's heavy hitters.
Broker tips: Marlowe, Fevertree
(Sharecast News) - Analysts at Berenberg slightly lowered their target price on software and services firm Marlowe from 720.0p to 710.0p on Tuesday but said the group's divestment of certain Governance, Risk and Compliance software and service assets had left it with a "much cleaner and simpler-to-understand equity story".
Director dealings: Tracsis non-executive director makes share purchase
(Sharecast News) - Tracsis revealed on Tuesday that non-executive director Ross Paterson acquired 4,814 ordinary shares in the AIM-listed software technology firm.
FTSE 100 movers: HSBC gains; Prudential in the red
(Sharecast News) - London's FTSE 100 was up 0.3% at 8,172.34 in afternoon trade on Tuesday.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.